diazepam has been researched along with oxprenolol in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (54.55) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghuloum, AM; Jain, AN; Sage, CR | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Ertl, P; Rohde, B; Selzer, P | 1 |
| Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
| Caron, G; Ermondi, G | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Elsdon-Dew, RW | 1 |
| Krishnan, G | 2 |
| Short, D | 1 |
| Johnson, G; Leeman, M; Singh, B | 1 |
| Burrows, GD; Davies, B; Fail, L; Poynton, C; Stevenson, H | 1 |
| Markomihelakis, H; Ogle, CW; Turner, P | 1 |
| McMillin, WP | 2 |
| Capek, D; Erdmann, G; Janke, W; Pohl, J | 1 |
| Belpaire, FM; Bogaert, MG; De Rick, A; Dello, C; Fraeyman, N | 1 |
| Price, J; Whitlock, FA | 1 |
| Brambach, U; Eibs, HG; Oberdisse, U | 1 |
| Erdmann, G; Janke, W; Köchers, S; Terschlüsen, B | 1 |
| Barnett, DB; Desai, N; Taylor-Davies, A | 1 |
| Blampied, NM; Kirk, RC | 1 |
| Scharbach, H | 1 |
| Hughes, RN | 1 |
1 review(s) available for diazepam and oxprenolol
| Article | Year |
|---|---|
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Diazepam; Humans; Hyperventilation; Mental Disorders; Oxprenolol; Propranolol; Schizophrenia; Sotalol; Substance Withdrawal Syndrome; Substance-Related Disorders; Sympathetic Nervous System; Tremor | 1974 |
7 trial(s) available for diazepam and oxprenolol
| Article | Year |
|---|---|
Oxprenolol in the treatment of examination stress.
Topics: Adolescent; Adult; Anxiety; Clinical Trials as Topic; Diazepam; Educational Measurement; Female; Humans; Oxprenolol; Stress, Psychological | 1976 |
Controlled evaluation of the beta adrenoceptor blocking drug oxprenolol in anxiety.
Topics: Adult; Anxiety; Clinical Trials as Topic; Diazepam; Female; Humans; Male; Oxprenolol; Placebos; Psychiatric Status Rating Scales; Time Factors | 1976 |
A placebo controlled trial of diazepam and oxprenolol for anxiety.
Topics: Adolescent; Adult; Anxiety; Clinical Trials as Topic; Diazepam; Female; Humans; Male; Middle Aged; Oxprenolol; Placebos | 1976 |
The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency.
Topics: Adult; Diazepam; Flicker Fusion; Humans; Lorazepam; Male; Motor Skills; Oxprenolol; Propranolol; Pulse; Reaction Time | 1976 |
Oxprenolol in anxiety.
Topics: Anxiety; Diazepam; Humans; Oxprenolol | 1973 |
The effects of diazepam and oxprenolol on short term memory in individuals of high and low state anxiety.
Topics: Adolescent; Adult; Anxiety; Diazepam; Female; Humans; Male; Memory, Short-Term; Oxprenolol | 1983 |
[A double blind trial : oxprenolol/diazepam (author's transl)].
Topics: Anxiety Disorders; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Oxprenolol | 1981 |
25 other study(ies) available for diazepam and oxprenolol
| Article | Year |
|---|---|
Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules.
Topics: Drug Design; Intestinal Absorption; Models, Molecular; Pharmaceutical Preparations; Structure-Activity Relationship | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
Topics: Biological Availability; Biological Transport; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Clinical trials of oxprenolol in anxiety.
Topics: Adrenergic beta-Antagonists; Anxiety; Climacteric; Diazepam; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Oxprenolol | 1975 |
Oxprenolol in the treatment of examination nerves.
Topics: Adrenergic beta-Antagonists; Anxiety; Diazepam; Humans; Oxprenolol; Self-Assessment; Stress, Psychological; Students | 1975 |
The management of the patient with angina.
Topics: Angina Pectoris; Anticoagulants; Clofibrate; Coronary Artery Bypass; Diazepam; Digoxin; Humans; Isosorbide Dinitrate; Nitroglycerin; Oxprenolol; Perhexiline; Prenylamine; Propranolol; Verapamil | 1977 |
Oxprenolol in the treatment of anxiety due to environmental stress.
Topics: Administration, Oral; Adult; Anxiety; Civil Disorders; Diazepam; Drug Administration Schedule; Drug Evaluation; Female; Humans; Northern Ireland; Oxprenolol; Stress, Psychological | 1975 |
The problem of influencing specific or unspecific emotional states by drugs: effects of a tranquilizer and two beta-blocking agents under noise conditions.
Topics: Adrenergic beta-Antagonists; Adult; Diazepam; Emotions; Hemodynamics; Humans; Male; Noise; Oxprenolol; Propanolamines; Tranquilizing Agents | 1988 |
Alpha 1-acid glycoprotein and serum binding of drugs in healthy and diseased dogs.
Topics: Animals; Blood Sedimentation; Diazepam; Digitoxin; Dog Diseases; Dogs; Female; Inflammation; Lidocaine; Male; Orosomucoid; Oxprenolol; Phenytoin; Propranolol; Protein Binding; Reference Values; Serum Albumin | 1987 |
[Intoxication with beta-receptor blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Antidotes; Bradycardia; Bundle-Branch Block; Bupranolol; Cardiac Complexes, Premature; Diazepam; Dopamine; Female; Glucagon; Humans; Hypotension; Isosorbide Dinitrate; Male; Metaproterenol; Middle Aged; Oxprenolol; Pacemaker, Artificial; Sotalol | 1982 |
Comparison of the emotional effects of a beta-adrenergic blocking agent and a tranquilizer under different situational conditions. I. Anxiety-arousing situations.
Topics: Adolescent; Adult; Anxiety; Arousal; Diazepam; Emotions; Humans; Male; Noise; Oxprenolol | 1984 |
Defensive burying: effects of diazepam and oxprenolol measured in extinction.
Topics: Animals; Avoidance Learning; Diazepam; Electroshock; Extinction, Psychological; Female; Oxprenolol; Rats; Rats, Inbred Strains | 1983 |
Oxprenolol and diazepam effects on activity, novelty preference and timidity in rats.
Topics: Aggression; Animals; Behavior, Animal; Choice Behavior; Diazepam; Environment; Exploratory Behavior; Female; Humans; Light; Male; Motor Activity; Oxprenolol; Rats | 1981 |